FL genes
Origins of FL genes
Tier 1 FL genes
| Gene | Tier | Relevant references |
|---|---|---|
| ACTB | 1 | (Lohr et al. 2012) |
| ARID1A | 1 | (Zhang et al. 2013; Love et al. 2012; Krysiak et al. 2017) |
| ATP6AP1 | 1 | (Okosun et al. 2016) |
| ATP6V1B2 | 1 | (Okosun et al. 2016) |
| B2M | 1 | (Morin et al. 2011) |
| BCL2 | 1 | (Tanaka et al. 1992; Morin et al. 2011; Burkhardt et al. 2022) |
| BCL6 | 1 | (Morin et al. 2011; Love et al. 2012) |
| BCL7A | 1 | (Grande et al. 2019; Krysiak et al. 2017; Arthur et al. 2018) |
| BIRC6 | 1 | (Reddy et al. 2017) |
| BTG1 | 1 | (Burkhardt et al. 2022; Morin et al. 2011) |
| BTG2 | 1 | (Love et al. 2012; Morin et al. 2011) |
| BTK | 1 | (Krysiak et al. 2017; Albuquerque et al. 2017) |
| CARD11 | 1 | (Panea et al. 2019; Morin et al. 2011; Lenz et al. 2008) |
| CCND3 | 1 | (Richter et al. 2012; Morin et al. 2011) |
| CD83 | 1 | (Panea et al. 2019; Russler-Germain et al. 2023; Morin et al. 2013) |
| CREBBP | 1 | (Love et al. 2012; Laura Pasqualucci, Dominguez-Sola, et al. 2011) |
| CTSS | 1 | (Bararia et al. 2020) |
| DTX1 | 1 | (Panea et al. 2019; Schmitz et al. 2018) |
| EBF1 | 1 | (Bohle et al. 2013; Thomas et al. 2023) |
| EEF1A1 | 1 | (Hübschmann et al. 2021) |
| EP300 | 1 | (Laura Pasqualucci, Dominguez-Sola, et al. 2011; Panea et al. 2019) |
| EZH2 | 1 | (Love et al. 2012; Morin et al. 2010) |
| FAS | 1 | (Scholl et al. 2007) |
| FOXO1 | 1 | (Schmitz et al. 2012; Morin et al. 2011) |
| GNA13 | 1 | (Morin et al. 2011; Love et al. 2012) |
| GNAI2 | 1 | (Grande et al. 2019; Morin et al. 2013) |
| HIST1H1B | 1 | (Krysiak et al. 2017; Chapuy et al. 2018) |
| HIST1H1C | 1 | (Morin et al. 2011; Panea et al. 2019) |
| HIST1H1D | 1 | (Morin et al. 2013; Krysiak et al. 2017) |
| HIST1H1E | 1 | (Krysiak et al. 2017; Grande et al. 2019; Morin et al. 2013) |
| HIST1H2AC | 1 | (Krysiak et al. 2017; Morin et al. 2013) |
| HIST1H2AG | 1 | (Panea et al. 2019; Krysiak et al. 2017; Morin et al. 2013) |
| HIST1H2AM | 1 | (Krysiak et al. 2017; Panea et al. 2019) |
| HIST1H2BC | 1 | (Reddy et al. 2017; Krysiak et al. 2017) |
| HIST1H2BD | 1 | (Krysiak et al. 2017) |
| HIST1H2BG | 1 | (Krysiak et al. 2017) |
| HIST1H3B | 1 | (Zhang et al. 2013) |
| HIST1H3G | 1 | (Krysiak et al. 2017) |
| HVCN1 | 1 | (Krysiak et al. 2017) |
| IRF4 | 1 | (Morin et al. 2011) |
| IRF8 | 1 | (Morin et al. 2011; Panea et al. 2019) |
| ITPKB | 1 | (Schmitz et al. 2018) |
| KLF2 | 1 | (Laura Pasqualucci, Trifonov, et al. 2011) |
| KLHL6 | 1 | (Morin et al. 2011; Panea et al. 2019) |
| KMT2D | 1 | (Grande et al. 2019; Morin et al. 2011) |
| LTB | 1 | (Chapuy et al. 2018; Panea et al. 2019) |
| MAP2K1 | 1 | (Louissaint et al. 2016; Shin et al. 2015) |
| MEF2B | 1 | (Morin et al. 2011) |
| MEF2C | 1 | (Arthur et al. 2018) |
| PCLO | 1 | (Lohr et al. 2012) |
| PIM1 | 1 | (L. Pasqualucci et al. 2001; Burkhardt et al. 2022) |
| POU2AF1 | 1 | (Krysiak et al. 2017) |
| POU2F2 | 1 | (Zhang et al. 2013; Krysiak et al. 2017) |
| PTPRD | 1 | [] |
| RRAGC | 1 | (Okosun et al. 2016) |
| S1PR2 | 1 | (Morin et al. 2011; Muppidi et al. 2014) |
| SGK1 | 1 | (Morin et al. 2011) |
| SMARCA4 | 1 | (Zhang et al. 2013; Krysiak et al. 2017; Richter et al. 2012) |
| SOCS1 | 1 | (Morin et al. 2011) |
| STAT6 | 1 | (Yildiz et al. 2015) |
| TBL1XR1 | 1 | (Mareschal et al. 2016) |
| TMSB4X | 1 | (Albuquerque et al. 2017) |
| TNFAIP3 | 1 | (Compagno et al. 2009) |
| TNFRSF14 | 1 | (Cheung et al. 2010) |
| TP53 | 1 | (Wilda et al. 2004; Morin et al. 2011) |
| VMA21 | 1 | (Hübschmann et al. 2021) |
Tier 2 FL genes
| Gene | Tier | Relevant references |
|---|---|---|
| ABL2 | 2 | (Russler-Germain et al. 2023) |
| ACTG1 | 2 | (Hübschmann et al. 2021) |
| ATP6V1A | 2 | (Hübschmann et al. 2021) |
| BCL10 | 2 | (Russler-Germain et al. 2023; Morin et al. 2011) |
| CCDC42BPB | 2 | (Hübschmann et al. 2021) |
| CD70 | 2 | (Russler-Germain et al. 2023; Morin et al. 2011) |
| CD79B | 2 | (Panea et al. 2019; Morin et al. 2011) |
| CILP | 2 | (Russler-Germain et al. 2023) |
| CPNE8 | 2 | (Hübschmann et al. 2021) |
| CXCR4 | 2 | (Panea et al. 2019; Krysiak et al. 2017; Khodabakhshi et al. 2012) |
| CYP2A6 | 2 | (Russler-Germain et al. 2023) |
| DDX3X | 2 | (Schmitz et al. 2012, 2018) |
| DHX15 | 2 | (Hübschmann et al. 2021) |
| DUSP2 | 2 | (Morin et al. 2013) |
| EGR1 | 2 | (Krysiak et al. 2017) |
| FZR1 | 2 | (Hübschmann et al. 2021) |
| GBP7 | 2 | (Russler-Germain et al. 2023) |
| GRM6 | 2 | (Russler-Germain et al. 2023) |
| HIST1H2BM | 2 | (Krysiak et al. 2017) |
| HIST1H3I | 2 | (Krysiak et al. 2017; Panea et al. 2019) |
| HLA-B | 2 | [] |
| HNRNPD | 2 | [] |
| IGLL5 | 2 | (Panea et al. 2019; Russler-Germain et al. 2023) |
| JUP | 2 | (Hübschmann et al. 2021) |
| KIR3DL1 | 2 | (Russler-Germain et al. 2023) |
| LAPTM5 | 2 | (Hübschmann et al. 2021) |
| MAGEC1 | 2 | (Russler-Germain et al. 2023) |
| MAP7D1 | 2 | (Russler-Germain et al. 2023) |
| MGEA5 | 2 | (Hübschmann et al. 2021) |
| MKI67 | 2 | (Russler-Germain et al. 2023; Schmitz et al. 2012) |
| MYC | 2 | (Johnston and Carroll 1992; L. Pasqualucci et al. 2001) |
| MYCBP2 | 2 | (Hübschmann et al. 2021) |
| MYD88 | 2 | (Ngo et al. 2011) |
| NFKBIA | 2 | (Russler-Germain et al. 2023; Lake et al. 2009) |
| OR8H2 | 2 | (Russler-Germain et al. 2023) |
| P2RY8 | 2 | (Lohr et al. 2012; Muppidi et al. 2014) |
| PDS5B | 2 | (Morin et al. 2013; Hübschmann et al. 2021) |
| PPP4C | 2 | (Hübschmann et al. 2021) |
| PRKDC | 2 | (Hübschmann et al. 2021; Schmitz et al. 2018) |
| PZP | 2 | (Russler-Germain et al. 2023) |
| RBM6 | 2 | (Hübschmann et al. 2021) |
| SESN1 | 2 | (Oricchio et al. 2017) |
| SHROOM3 | 2 | (Russler-Germain et al. 2023) |
| SRRM2 | 2 | (Russler-Germain et al. 2023; Morin et al. 2013) |
| STAB2 | 2 | (Russler-Germain et al. 2023) |
| TMEM30A | 2 | (Morin et al. 2011) |
| TPP1 | 2 | (Hübschmann et al. 2021) |
| XIRP2 | 2 | (Russler-Germain et al. 2023) |
| ZC3H12A | 2 | (Arthur et al. 2018) |
| ZNF608 | 2 | (Krysiak et al. 2017; Zhang et al. 2013) |
References
Albuquerque, Marco A., Bruno M. Grande, Elie J. Ritch, Prasath
Pararajalingam, Selin Jessa, Martin Krzywinski, Jasleen K. Grewal,
Sohrab P. Shah, Paul C. Boutros, and Ryan D. Morin. 2017. “Enhancing
Knowledge Discovery from Cancer Genomics Data with Galaxy.”
GigaScience 6 (5): 1–13. https://doi.org/10.1093/gigascience/gix015.
Arthur, Sarah E., Aixiang Jiang, Bruno M. Grande, Miguel Alcaide, Razvan
Cojocaru, Christopher K. Rushton, Anja Mottok, et al. 2018. “Genome-Wide
Discovery of Somatic Regulatory Variants in Diffuse Large B-cell Lymphoma.” Nature Communications 9
(1): 4001. https://doi.org/10.1038/s41467-018-06354-3.
Bararia, Deepak, Johannes A. Hildebrand, Sebastian Stolz, Sarah Haebe,
Stefan Alig, Christopher P. Trevisani, Francisco Osorio-Barrios, et al.
2020. “Cathepsin S Alterations Induce a Tumor-Promoting Immune
Microenvironment in Follicular Lymphoma.” Cell Reports 31 (5):
107522. https://doi.org/10.1016/j.celrep.2020.107522.
Bohle, V., C. Döring, M.-L. Hansmann, and R. Küppers. 2013. “Role of
Early B-cell Factor 1 (EBF1) in Hodgkin
Lymphoma.” Leukemia 27 (3): 671–79. https://doi.org/10.1038/leu.2012.280.
Burkhardt, Birgit, Ulf Michgehl, Jonas Rohde, Tabea Erdmann, Philipp
Berning, Katrin Reutter, Marius Rohde, et al. 2022. “Clinical Relevance
of Molecular Characteristics in Burkitt Lymphoma Differs According to
Age.” Nature Communications 13 (1): 3881. https://doi.org/10.1038/s41467-022-31355-8.
Chapuy, Bjoern, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas
Kamburov, Robert A. Redd, Mike S. Lawrence, et al. 2018. “Molecular
Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct
Pathogenic Mechanisms and Outcomes.” Nature Medicine 24 (5):
679–90. https://doi.org/10.1038/s41591-018-0016-8.
Cheung, K.-John J., Nathalie A. Johnson, Joslynn G. Affleck, Tesa
Severson, Christian Steidl, Susana Ben-Neriah, Jacqueline Schein, et al.
2010. “Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated
with Worse Prognosis.” Cancer Research 70 (22): 9166–74. https://doi.org/10.1158/0008-5472.CAN-10-2460.
Compagno, Mara, Wei Keat Lim, Adina Grunn, Subhadra V. Nandula, Manisha
Brahmachary, Qiong Shen, Francesco Bertoni, et al. 2009. “Mutations of
Multiple Genes Cause Deregulation of NF-kappaB in Diffuse Large B-cell Lymphoma.” Nature 459 (7247):
717–21. https://doi.org/10.1038/nature07968.
Grande, Bruno M., Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner,
Jeremy S. Abramson, Thomas B. Alexander, Hilary Allen, et al. 2019.
“Genome-Wide Discovery of Somatic Coding and Noncoding Mutations in
Pediatric Endemic and Sporadic Burkitt Lymphoma.” Blood 133
(12): 1313–24. https://doi.org/10.1182/blood-2018-09-871418.
Hübschmann, Daniel, Kortine Kleinheinz, Rabea Wagener, Stephan H.
Bernhart, Cristina López, Umut H. Toprak, Stephanie Sungalee, et al.
2021. “Mutational Mechanisms Shaping the Coding and Noncoding Genome of
Germinal Center Derived B-cell Lymphomas.”
Leukemia 35 (7): 2002–16. https://doi.org/10.1038/s41375-021-01251-z.
Johnston, J. M., and W. L. Carroll. 1992. “C-Myc Hypermutation in
Burkitt’s Lymphoma.” Leukemia & Lymphoma 8 (6): 431–39. https://doi.org/10.3109/10428199209051025.
Khodabakhshi, Alireza Hadj, Ryan D. Morin, Anthony P. Fejes, Andrew J.
Mungall, Karen L. Mungall, Madison Bolger-Munro, Nathalie A. Johnson, et
al. 2012. “Recurrent Targets of Aberrant Somatic Hypermutation in
Lymphoma.” Oncotarget 3 (11): 1308–19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717795/.
Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock,
Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017.
“Recurrent Somatic Mutations Affecting B-cell Receptor Signaling Pathway Genes in
Follicular Lymphoma.” Blood 129 (4): 473–83. https://doi.org/10.1182/blood-2016-07-729954.
Lake, Annette, Lesley A. Shield, Pablo Cordano, Daniel T. Y. Chui, Julie
Osborne, Shauna Crae, Katherine S. Wilson, et al. 2009. “Mutations of
NFKBIA, Encoding IkappaB Alpha, Are a Recurrent Finding in Classical
Hodgkin Lymphoma but Are Not a Unifying Feature of Non-EBV-associated Cases.” International Journal
of Cancer 125 (6): 1334–42. https://doi.org/10.1002/ijc.24502.
Lenz, Georg, R Eric Davis, Vu N Ngo, Lloyd Lam, Thaddeus C George,
George W Wright, Sandeep S Dave, et al. 2008. “Oncogenic CARD11
Mutations in Human Diffuse Large B Cell Lymphoma.” Science 319
(5870): 1676–79.
Lohr, Jens G., Petar Stojanov, Michael S. Lawrence, Daniel Auclair,
Bjoern Chapuy, Carrie Sougnez, Peter Cruz-Gordillo, et al. 2012.
“Discovery and Prioritization of Somatic Mutations in Diffuse Large
B-cell Lymphoma (DLBCL) by Whole-Exome
Sequencing.” Proceedings of the National Academy of Sciences of the
United States of America 109 (10): 3879–84. https://doi.org/10.1073/pnas.1121343109.
Louissaint, Abner, Kristian T. Schafernak, Julia T. Geyer, Alexandra E.
Kovach, Mahmoud Ghandi, Dita Gratzinger, Christine G. Roth, et al. 2016.
“Pediatric-Type Nodal Follicular Lymphoma: A Biologically Distinct
Lymphoma with Frequent MAPK Pathway Mutations.” Blood 128 (8):
1093–1100. https://doi.org/10.1182/blood-2015-12-682591.
Love, Cassandra, Zhen Sun, Dereje Jima, Guojie Li, Jenny Zhang, Rodney
Miles, Kristy L. Richards, et al. 2012. “The Genetic Landscape of
Mutations in Burkitt Lymphoma.” Nature Genetics 44 (12):
1321–25. https://doi.org/10.1038/ng.2468.
Mareschal, Sylvain, Sydney Dubois, Pierre-Julien Viailly, Philippe
Bertrand, Elodie Bohers, Catherine Maingonnat, Jean-Philippe Jaïs, et
al. 2016. “Whole Exome Sequencing of Relapsed/Refractory Patients
Expands the Repertoire of Somatic Mutations in Diffuse Large B-cell Lymphoma.” Genes, Chromosomes &
Cancer 55 (3): 251–67. https://doi.org/10.1002/gcc.22328.
Morin, Ryan D., Nathalie A. Johnson, Tesa M. Severson, Andrew J.
Mungall, Jianghong An, Rodrigo Goya, Jessica E. Paul, et al. 2010.
“Somatic Mutations Altering EZH2 (Tyr641) in Follicular and Diffuse
Large B-cell Lymphomas of Germinal-Center
Origin.” Nature Genetics 42 (2): 181–85. https://doi.org/10.1038/ng.518.
Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya,
Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011.
“Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.”
Nature 476 (7360): 298–303. https://doi.org/10.1038/nature10351.
Morin, Ryan D., Karen Mungall, Erin Pleasance, Andrew J. Mungall,
Rodrigo Goya, Ryan D. Huff, David W. Scott, et al. 2013. “Mutational and
Structural Analysis of Diffuse Large B-cell
Lymphoma Using Whole-Genome Sequencing.” Blood 122 (7):
1256–65. https://doi.org/10.1182/blood-2013-02-483727.
Muppidi, J., R. Schmitz, Jesse A. Green, Jesse A. Green, Wenming Xiao,
Adrien B. Larsen, S. Braun, et al. 2014. “Loss of Signaling via Gα13 in
Germinal Center B Cell-Derived Lymphoma.” Nature 516: 254–58.
https://doi.org/10.1038/nature13765.
Ngo, Vu N., Ryan M. Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao,
Kian-Huat Lim, Holger Kohlhammer, et al. 2011. “Oncogenically Active
MYD88 Mutations in Human Lymphoma.” Nature 470 (7332): 115–19.
https://doi.org/10.1038/nature09671.
Okosun, Jessica, Rachel L. Wolfson, Jun Wang, Shamzah Araf, Lucy
Wilkins, Brian M. Castellano, Leire Escudero-Ibarz, et al. 2016.
“Recurrent mTORC1-activating RRAGC Mutations
in Follicular Lymphoma.” Nature Genetics 48 (2): 183–88. https://doi.org/10.1038/ng.3473.
Oricchio, Elisa, Natalya Katanayeva, Maria Christine Donaldson,
Stephanie Sungalee, Joyce P. Pasion, Wendy Béguelin, Elena Battistello,
et al. 2017. “Genetic and Epigenetic Inactivation of SESTRIN1 Controls
mTORC1 and Response to EZH2 Inhibition in
Follicular Lymphoma.” Science Translational Medicine 9 (396):
eaak9969. https://doi.org/10.1126/scitranslmed.aak9969.
Panea, R., C. Love, Jennifer R. Shingleton, Anupama Reddy, J. Bailey, A.
Moormann, J. Otieno, et al. 2019. “The Whole Genome Landscape of Burkitt
Lymphoma Subtypes.” Blood. https://doi.org/10.1182/blood.2019001880.
Pasqualucci, Laura, David Dominguez-Sola, Annalisa Chiarenza, Giulia
Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H. Kasper, et al. 2011.
“Inactivating Mutations of Acetyltransferase Genes in B-cell Lymphoma.” Nature 471 (7337):
189–95. https://doi.org/10.1038/nature09730.
Pasqualucci, Laura, Vladimir Trifonov, Giulia Fabbri, Jing Ma, Davide
Rossi, Annalisa Chiarenza, Victoria A. Wells, et al. 2011. “Analysis of
the Coding Genome of Diffuse Large B-cell
Lymphoma.” Nature Genetics 43 (9): 830–37. https://doi.org/10.1038/ng.892.
Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R. S.
Chaganti, R. Küppers, and R. Dalla-Favera. 2001. “Hypermutation of
Multiple Proto-Oncogenes in B-cell Diffuse
Large-Cell Lymphomas.” Nature 412 (6844): 341–46. https://doi.org/10.1038/35085588.
Reddy, Anupama, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt,
Cassandra L Love, Alexander Waldrop, Sirpa Leppa, et al. 2017. “Genetic
and Functional Drivers of Diffuse Large B Cell Lymphoma.” Cell
171 (2): 481–494.e15.
Richter, Julia, Matthias Schlesner, Steve Hoffmann, Markus Kreuz, Ellen
Leich, Birgit Burkhardt, Maciej Rosolowski, et al. 2012. “Recurrent
Mutation of the ID3 Gene in Burkitt Lymphoma Identified by Integrated
Genome, Exome and Transcriptome Sequencing.” Nature Genetics 44
(12): 1316–20. https://doi.org/10.1038/ng.2469.
Russler-Germain, David A., Kilannin Krysiak, Cody A. Ramirez, Matthew
Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, et al.
2023. “Mutations Associated with Progression in Follicular Lymphoma
Predict Inferior Outcomes at Diagnosis: Alliance A151303.” Blood
Advances 7: 5524–39. https://doi.org/10.1182/bloodadvances.2023010779.
Schmitz, Roland, George W. Wright, Da Wei Huang, Calvin A. Johnson,
James D. Phelan, James Q. Wang, Sandrine Roulland, et al. 2018.
“Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.” The
New England Journal of Medicine 378 (15): 1396–1407. https://doi.org/10.1056/NEJMoa1801445.
Schmitz, Roland, Ryan M. Young, Michele Ceribelli, Sameer Jhavar,
Wenming Xiao, Meili Zhang, George Wright, et al. 2012. “Burkitt Lymphoma
Pathogenesis and Therapeutic Targets from Structural and Functional
Genomics.” Nature 490 (7418): 116–20. https://doi.org/10.1038/nature11378.
Scholl, Vanesa, Claudio Gustavo Stefanoff, Rocio Hassan, Nelson Spector,
and Ilana Zalcberg Renault. 2007. “Mutations Within the 5’ Region of
FAS/CD95 Gene in Nodal Diffuse Large B-cell
Lymphoma.” Leukemia & Lymphoma 48 (5): 957–63. https://doi.org/10.1080/10428190701230858.
Shin, Sang-Yong, Seung-Tae Lee, Hee-Jin Kim, Chang-Seok Ki, Chul Won
Jung, Jong-Won Kim, and Sun-Hee Kim. 2015. “BRAF V600E and MAP2K1
Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma
Cases.” Annals of Laboratory Medicine 35 (2): 257–59. https://doi.org/10.3343/alm.2015.35.2.257.
Tanaka, S., D. C. Louie, J. A. Kant, and J. C. Reed. 1992. “Frequent
Incidence of Somatic Mutations in Translocated BCL2 Oncogenes of
Non-Hodgkin’s Lymphomas.” Blood 79 (1): 229–37.
Thomas, Nicole, Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton,
Jeremy S. Abramson, Richard F. Ambinder, Stefan Barta, et al. 2023.
“Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt
Lymphoma.” Blood 141 (8): 904–16. https://doi.org/10.1182/blood.2022016534.
Wilda, M., J. Bruch, L. Harder, D. Rawer, A. Reiter, A. Borkhardt, and
W. Woessmann. 2004. “Inactivation of the ARF-MDM-2-p53 Pathway in Sporadic Burkitt’s
Lymphoma in Children.” Leukemia 18 (3): 584–88. https://doi.org/10.1038/sj.leu.2403254.
Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter
Ouillette, Siân Jones, Kamlai Saiya-Cork, et al. 2015. “Activating STAT6
Mutations in Follicular Lymphoma.” Blood 125 (4): 668–79. https://doi.org/10.1182/blood-2014-06-582650.
Zhang, Jenny, Vladimir Grubor, Cassandra L Love, Anjishnu Banerjee,
Kristy L Richards, Piotr A Mieczkowski, Cherie Dunphy, et al. 2013.
“Genetic Heterogeneity of Diffuse Large B-cell Lymphoma.” January.
Citing
If you use the information or data from this site, please cite
Krysta Coyle, Kostiantyn Dreval, Daniel Hodson and Ryan D. Morin. Audit of B-cell cancer genes. Blood Adv (2025) 9 (8): 2019–2031.
Disclaimer
The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.
